Icon Genetics GmbH

Icon Genetics GmbH (Halle/Saale, Germany) is the world leader in developing and using expression systems for production of recombinant proteins in green plants. The company has established a new generation production platform, and holds a dominant patent portfolio composed of over 400 granted patents in the field of plant-based expression systems.
Icon Genetics has built an efficient research and development pipeline for a number of biopharmaceuticals including preventive and therapeutic vaccines, as well as recombinant proteins for diagnostic use.
The company has built its own GMP-certified facility for R&D purposes, and a quality control department. It has also established a quality management system according to EU GMP guidelines. Icon Genetics is experienced in running FDA-approved clinical trials.